Drugs / Recombinant Human IGF-1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00684957 Comparator | Jan 2008 → Oct 2012 | pituitary deficiency | Columbia University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Human IGF-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00684957 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Human IGF-1” NCT00684957 ↗ |